Evidence map›Paper›PMID 29374343›Full record

ArticleMolecular imaging and biology2018

Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [

Joshua M Goldenberg, Julio Cárdenas-Rodríguez, Mark D Pagel

Open access · greenAbstract read
In one paragraph

Article in Molecular imaging and biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Multimodal Imaging of Hypoxia, Metabolism and pH in Feline Sarcoma Using HyperpolarizedAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of metformin onThe British journal of radiology · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Joshua M GoldenbergDepartment of Pharmaceutical Sciences, The University of Arizona, Tucson, AZ, 85721, USA.
Julio Cárdenas-RodríguezBanner - University Medical Center, The University of Arizona, Tucson, AZ, 85724, USA.
Mark D PagelDepartment of Cancer Systems Imaging, The University of Texas M.D. Anderson Cancer Center, 3SCR4.3642, Unit 1907, Houston, TX, 77054-1901, USA. mdpagel@mdanderson.org.
Banner - University Medical Center Tucson · USThe University of Texas MD Anderson Cancer Center · USUniversity of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
Measuring extracellular pH in pre-clinical tumor models with CEST MRIR01CA167183 · NCI · UNIVERSITY OF ARIZONA · PI PAGEL, MARK DAVID · 2012 to 2015
$1.6M
NCI NIH HHS P30 CA023074NCI NIH HHS P50 CA095060NCI NIH HHS R01 CA167183
6 · The paper itself

Abstract

purposeWe sought to determine if the synergy between evaluations of glucose uptake in tumors and extracellular tumor acidosis measured with simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) can improve longitudinal evaluations of the response to metformin treatment. PROCEDURES: A standard 2-deoxy-2-[

resultsMRI acquisition protocols had little effect on the PET count rate, and the PET instrumentation had little effect on image contrast during acidoCEST MRI, verifying that [

conclusions[

Indexed as

Magnetic Resonance ImagingPositron-Emission TomographyAnimalsBiomarkers, TumorCell Line, TumorFemaleFluorodeoxyglucose F18HumansMetforminMice, SCIDPancreatic NeoplasmsBiomarkers, TumorFluorodeoxyglucose F18Metformin[18F]FDG PETacidoCEST MRIMetforminPET/MRI

Identifiers

PMID29374343
PMCPMC6043393
OpenAlexW2790617352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.